Lucid Diagnostics Inc. (LUCD) Reports In-Line Q3 EPS

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $792.69 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• After-Hours Stock Movers: FDX, CBRS, NKE
• BofA lists top 5 themes driving next $1tn in incremental semi sales